Loan Notes1 Jun 2019 08:48
Did anyone notice that the 3 year 4% interest had been rolled up in to the total number of shares ? I certainly didnee until Pom pointed out the error of my ways......
From the announcement 719,435,294 shares at 0.2125HKD = 152.88mill HKD (you will notice that figure is not mentioned anywhere) which is 719,435,294(1-1/1.12)=77,082,352 shares. The figure that is mentioned = 136.5mill HKD, so a 12% up front increase in shares as interest payment. And, although they show the % increase, are they not trying to deceive shareholders by not clearly stating how much its going to cost us?
Also, surely it would be in our best interest to make the payments to them at the end of each year, otherwise their 4% repayment is effectively going to be much more as the share price increases. i.e if the SP were to triple in 3 years (not impossible), that means their interest payment will be 77,082,353 shares x 0.75HKD(based on 0.25) = 57.8millHKD in interest which is 49+% on the proposed discounted SP value. 49% would back calculate to an annual compounded interest of 14% (3.5 times more than 4%). Is it normal to pay upfront interest on loans before monies have been used ?
I wont contemplate a "what if the SP drops lower scenario". That is nonsensical given we are purchasing Yooya with expected growth (otherwise why spend the money) and we should have completed the FDA process by then too. Which is probably why they have gone for broke in providing a 3 year loan since they obviously have huge expectations over the next 2 to 3 years.
I also notice that they refer to "Previously Advanced Funds and deferred salaries" of 42.9mill HKD (5.5mill USD). Other than now, when were shareholders advised of these ?.....Have I been completely ignorant and missed all these ? (appreciate if anyone can point out when and in what announcement shareholders were advised). Are these things not price sensitive considering the are part of the companies financing ?
Obviously the above are just speculative figures on future SP, but as mentioned, not impossible given we will probably have FDA approval by then, income from Yooya and surely better Fortacin sales figures under our belts.
If anyone disagrees with the above workings or feel I have made mistakes, please let me know, its all open to discussion.